Scarica l'app Stockscreener
15.32
1.92%
-0.30
Dopo l'orario di chiusura:
15.32
Precedente Chiudi:
$15.62
Aprire:
$15.43
Volume 24 ore:
726.14K
Relative Volume:
0.91
Capitalizzazione di mercato:
$1.61B
Reddito:
-
Utile/perdita netta:
$-150.70M
Rapporto P/E:
-9.8839
EPS:
-1.55
Flusso di cassa netto:
$-125.67M
1 W Prestazione:
-4.55%
1M Prestazione:
+8.96%
6M Prestazione:
+17.57%
1 anno Prestazione:
-56.27%
Intervallo 1D:
$15.00
$16.60
Intervallo di 1 settimana:
$14.25
$16.60
Portata 52W:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Nome
Edgewise Therapeutics Inc
Settore
Industria
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER
Confronta EWTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
15.32 | 1.55B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-25 | Iniziato | Goldman | Neutral |
| 2025-07-30 | Iniziato | Raymond James | Strong Buy |
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-30 | Iniziato | Guggenheim | Buy |
| 2025-04-02 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-01-22 | Iniziato | Stifel | Hold |
| 2024-11-22 | Iniziato | Evercore ISI | Outperform |
| 2024-03-07 | Iniziato | Piper Sandler | Overweight |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2022-08-25 | Downgrade | Goldman | Neutral → Sell |
| 2022-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-01-28 | Iniziato | Goldman | Neutral |
Mostra tutto
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Price momentum metrics for Edgewise Therapeutics Inc. explainedOptions Play & Real-Time Volume Trigger Notifications - newser.com
Why Edgewise Therapeutics Inc. is moving todayWeekly Investment Summary & Low Risk Entry Point Guides - newser.com
Multi asset correlation models including Edgewise Therapeutics Inc.Earnings Miss & Real-Time Volume Analysis Alerts - newser.com
How to build a custom watchlist for Edgewise Therapeutics Inc.2025 Support & Resistance & Verified Short-Term Trading Plans - newser.com
Edgewise Therapeutics Inc. stock trend forecastJuly 2025 EndofMonth & Real-Time Volume Triggers - newser.com
What valuation multiples suggest for Edgewise Therapeutics Inc. stockQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - newser.com
Can a trend reversal in Edgewise Therapeutics Inc. lead to recoveryJuly 2025 Trends & Safe Capital Growth Tips - newser.com
What recovery options are there for Edgewise Therapeutics Inc.Quarterly Growth Report & Daily Entry Point Alerts - newser.com
Key metrics from Edgewise Therapeutics Inc.’s quarterly data2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Building trade automation scripts for Edgewise Therapeutics Inc.July 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
Is Edgewise Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
How to use a screener to detect Edgewise Therapeutics Inc. breakoutsMarket Movers & Risk Controlled Stock Alerts - newser.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Can Edgewise Therapeutics Inc. stock beat analyst upgrades2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
What analysts say about Edgewise Therapeutics Inc stockMACD Trading Signals & Fast Growing Stocks - earlytimes.in
What drives Edgewise Therapeutics Inc stock priceHigh Frequency Trading Trends & High Return Stock Ideas - earlytimes.in
Edgewise Therapeutics (EWTX): Exploring Valuation After Positive Long-Term Data on Sevasemten in Muscular Dystrophy Trials - Sahm
How high can Edgewise Therapeutics Inc. stock goJuly 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 5.1%Here's What Happened - MarketBeat
Edgewise Therapeutics, Inc.Common Stock (Nasdaq:EWTX) Price Chart | News | postregister.com - FinancialContent
Applying Elliott Wave Theory to Edgewise Therapeutics Inc.Portfolio Return Report & Technical Entry and Exit Tips - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Edgewise Therapeutics (NASDAQ:EWTX) - MarketBeat
How Investors May Respond To Edgewise Therapeutics (EWTX) Long-Term Sevasemten Data at World Muscle Congress - Yahoo Finance
Edgewise Therapeutics (EWTX): Evaluating Valuation as New Long-Term Clinical Data Sparks Investor Interest - Yahoo Finance
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring A 135.53% Upside Potential - DirectorsTalk Interviews
How Investors Are Reacting To Edgewise Therapeutics (EWTX) Unveiling Long-Term Data for Sevasemten at WMS 2025 - Sahm
Edgewise Therapeutics presents muscular dystrophy research at Vienna conference - Traders Union
Tools to monitor Edgewise Therapeutics Inc. recovery probabilityWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Eastern Progress
Edgewise Therapeutics (EWTX): Reviewing Valuation After Recent Momentum Shifts - Sahm
Edgewise Therapeutics, Inc. $EWTX Shares Acquired by HighMark Wealth Management LLC - MarketBeat
Best data tools to analyze Edgewise Therapeutics Inc. stockTrade Entry Report & Smart Money Movement Tracker - newser.com
Will earnings trigger a reversal in Edgewise Therapeutics Inc.Weekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Edgewise Therapeutics reports inducement grants as permitted by Nasdaq listing rules - MarketScreener
Breakthrough Muscular Dystrophy Treatment: Edgewise's Sevasemten Shows Disease Stabilization in Key Trials - Stock Titan
Wall Street Analysts Think Edgewise Therapeutics (EWTX) Could Surge 182%: Read This Before Placing a Bet - MSN
Is Edgewise Therapeutics Inc a good long term investmentShort-Term Trading Alerts & Set Up Real-Time Alerts – It’s Free - earlytimes.in
Edgewise Therapeutics (NASDAQ:EWTX) Raised to "Hold" at The Goldman Sachs Group - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 8.5%Here's Why - MarketBeat
The Goldman Sachs Group Begins Coverage on Edgewise Therapeutics (NASDAQ:EWTX) - MarketBeat
Goldman Sachs Initiates Coverage of Edgewise Therapeutics (EWTX) with Neutral Recommendation - Nasdaq
Goldman Sachs initiates Edgewise Therapeutics stock with Neutral rating By Investing.com - Investing.com Canada
Edgewise Therapeutics (NASDAQ:EWTX) Trading 8.5% HigherShould You Buy? - MarketBeat
Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Edgewise Therapeutics Inc Azioni (EWTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Russell Alan J | Chief Scientific Officer |
Aug 26 '25 |
Sale |
14.60 |
100,000 |
1,459,760 |
23,400 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):